在CKD和IgA脏病中进行尿组分析
Zewen Li1, Nianyi Zeng1, Xin Zhao1
1Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Clinical kidney journal
|November 2, 2023
概括
这项研究引入了一种使用MALDI-TOF MS检测慢性病 (CKD) 和免疫球蛋白A病 (IgAN) 的新型尿液测试. 这种非侵入性方法提供了一种可靠的方法,可以早期识别功能障碍及其亚型.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 分析化学 分析化学
背景情况:
- 慢性病 (CKD) 是一个全球性的健康挑战,特别是在老年人群中.
- 目前用于早期CKD检测和区分免疫球蛋白A脏病 (IgAN) 的方法通常依赖于侵入性脏活检.
- 对于早期识别功能障碍的非侵入性诊断工具有着至关重要的需求.
研究的目的:
- 开发和验证用于检测CKD及其Igan亚型的非侵入性诊断平台.
- 利用尿路形状来区分CKD患者与健康对照.
- 使用蛋白质组模式,从其他脏病亚型中识别IGAN患者.
主要方法:
- 一个病例控制研究,涉及健康对照和活检确认的CKD患者.
- 使用矩阵辅助激光吸附离子化-飞行时间 (MALDI-TOF) 质谱法 (MS) 分析尿液形状.
- 基于尿模式和各种算法的诊断模型的开发和评估,以确保稳定性和可重复性.
主要成果:
- 建立了一个基于MALDI-TOF MS尿模式的快速准确的CKD和IGAN检测平台.
- 诊断模型成功地将CKD患者与对照患者区分开来,并将Igan患者与其他病患者区分开来.
- 诊断模型在不同的算法中表现出令人满意的稳定性和可重复性.
结论:
- 发现的CKD相关和Igan特定的尿可以精确识别功能障碍及其亚型.
- 这些发现为查功能障碍提供了可靠的框架,并有助于理解病的发病因子.
- 这种方法可以确定脏疾病临床管理的潜在蛋白质标.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
18
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
18
01:28Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:29Acute Kidney Injury III: Clinical Manifestations
11
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
11
01:29Urine Studies I: Urinalysis
21
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
21
01:25Chronic Kidney Disease I: Introduction
17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17